Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
205.40
+8.16 (4.14%)
Jul 16, 2026, 11:33 AM EDT - Market open

Biogen Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
30,32525,81822,29637,49639,90435,268
Market Cap Growth
64.15%15.80%-40.54%-6.04%13.15%-5.49%
Enterprise Value
30,93428,57926,55143,78441,61639,133
Last Close Price
205.40175.99152.92258.77276.92239.92
PE Ratio
21.2220.0213.6832.4713.2723.07
Forward PE
15.9313.669.7117.5417.7013.94
PEG Ratio
8.294.751.904.3817.6839.30
PS Ratio
2.932.612.303.813.923.21
PB Ratio
1.561.411.332.532.983.24
P/TBV Ratio
9.7310.0140.87173.476.9712.32
P/FCF Ratio
12.0212.598.1929.5234.8810.43
P/OCF Ratio
11.2411.717.7524.2328.839.69
EV/Sales Ratio
3.112.892.744.454.093.56
EV/EBITDA Ratio
8.7410.829.0820.7810.4011.76
EV/EBIT Ratio
11.3015.3511.8027.1611.9513.78
EV/FCF Ratio
12.7713.949.7534.4736.3811.57
Debt / Equity Ratio
0.350.360.290.490.490.60
Debt / EBITDA Ratio
2.402.492.273.481.652.28
Debt / FCF Ratio
2.713.212.445.785.782.25
Net Debt / Equity Ratio
0.100.150.260.430.130.35
Net Debt / EBITDA Ratio
0.661.051.462.980.431.14
Net Debt / FCF Ratio
0.751.351.564.951.511.12
Asset Turnover
0.340.340.350.380.420.45
Inventory Turnover
1.181.040.931.311.691.74
Quick Ratio
2.181.700.770.922.151.34
Current Ratio
3.062.681.352.002.991.83
Return on Equity (ROE)
7.43%7.39%10.36%8.24%24.33%15.96%
Return on Assets (ROA)
5.55%5.38%7.02%5.62%11.85%11.36%
Return on Invested Capital (ROIC)
7.88%7.37%9.16%7.98%19.21%17.97%
Return on Capital Employed (ROCE)
7.35%7.66%9.80%7.22%17.05%14.04%
Earnings Yield
4.71%4.99%7.31%3.08%7.54%4.33%
FCF Yield
8.32%7.94%12.21%3.39%2.87%9.59%
Buyback Yield / Dilution
-1.01%-0.82%-0.21%0.27%2.41%7.25%
Total Shareholder Return
-1.01%-0.82%-0.21%0.27%2.41%7.25%
SEC Filings: 10-K · 10-Q